Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$21.07 - $29.77 $75,830 - $107,142
3,599 New
3,599 $97,000
Q2 2023

Jul 18, 2023

BUY
$13.33 - $25.53 $54,666 - $104,698
4,101 Added 144.05%
6,948 $163,000
Q1 2023

Apr 13, 2023

BUY
$13.49 - $18.72 $15,324 - $21,265
1,136 Added 66.39%
2,847 $39,000
Q4 2022

Jan 23, 2023

SELL
$14.47 - $18.17 $549 - $690
-38 Reduced 2.17%
1,711 $0
Q3 2022

Oct 26, 2022

SELL
$9.24 - $15.79 $53,730 - $91,818
-5,815 Reduced 76.88%
1,749 $26,000
Q2 2022

Jul 25, 2022

SELL
$8.28 - $13.88 $235,408 - $394,622
-28,431 Reduced 78.99%
7,564 $104,000
Q1 2022

May 02, 2022

BUY
$11.18 - $24.02 $53,943 - $115,896
4,825 Added 15.48%
35,995 $402,000
Q4 2021

Jan 28, 2022

BUY
$20.95 - $26.88 $653,011 - $837,849
31,170 New
31,170 $736,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.28B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.